Marcos Navares-Gómez

8PUBLICATIONS
17CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Characterisation of biological macromoleculesPredictive and prognostic markersPharmacogenomicsCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 23, 2023
Impact of CYP2D6 and CYP2B6 phenotypes on the response to tramadol in patients with acute post-surgical pain.

Ana Casajús, Pablo Zubiaur, Enrique Alday

|Sep 06, 2022
CYP2C8*3 and *4 define CYP2C8 phenotype: An approach with the substrate cinitapride.

Diana María Campodónico, Pablo Zubiaur, Paula Soria-Chacartegui

|Dec 28, 2021
Clinical Relevance of Novel Polymorphisms in the Dihydropyrimidine Dehydrogenase (DPYD) Gene in Patients with Severe Fluoropyrimidine Toxicity: A Spanish Case-Control Study.

Paula Soria-Chacartegui, Gonzalo Villapalos-García, Luis A López-Fernández

|Oct 23, 2021
Variants in COMT, CYP3A5, CYP2B6, and ABCG2 Alter Quetiapine Pharmacokinetics.

Pablo Zubiaur, Paula Fernández-Campos, Marcos Navares-Gómez

|Apr 03, 2021
SLCO1B1 Phenotype and CYP3A5 Polymorphism Significantly Affect Atorvastatin Bioavailability.

Pablo Zubiaur, Maria Dolores Benedicto, Gonzalo Villapalos-García

|Sep 29, 2020
Safety and cardiovascular effects of multiple-dose administration of aripiprazole and olanzapine in a randomised clinical trial.

Dora Koller, Susana Almenara, Gina Mejía

Pageof 2

Frequent Collaborators

8 joint publications

Pablo Zubiaur

8 joint publications

Francisco Abad-Santos

5 joint publications

Gina Mejía-Abril

5 joint publications

Gonzalo Villapalos-García